Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7N44

Crystal structure of the SARS-CoV-2 (2019-NCoV) main protease in complex with 5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione (compound 13)

7N44 の概要
エントリーDOI10.2210/pdb7n44/pdb
分子名称3C-like proteinase, 5-(3-{3-chloro-5-[(5-methyl-1,3-thiazol-4-yl)methoxy]phenyl}-2-oxo-2H-[1,3'-bipyridin]-5-yl)pyrimidine-2,4(1H,3H)-dione (3 entities in total)
機能のキーワードnovel coronavirus, antiviral, drug design, viral protein, hydrolase
由来する生物種Severe acute respiratory syndrome coronavirus 2 (2019-nCoV, SARS-CoV-2)
タンパク質・核酸の鎖数1
化学式量合計34345.51
構造登録者
Reilly, R.A.,Zhang, C.H.,Deshmukh, M.G.,Ippolito, J.A.,Hollander, K.,Jorgensen, W.L.,Anderson, K.S. (登録日: 2021-06-03, 公開日: 2021-07-21, 最終更新日: 2023-10-18)
主引用文献Zhang, C.H.,Spasov, K.A.,Reilly, R.A.,Hollander, K.,Stone, E.A.,Ippolito, J.A.,Liosi, M.E.,Deshmukh, M.G.,Tirado-Rives, J.,Zhang, S.,Liang, Z.,Miller, S.J.,Isaacs, F.,Lindenbach, B.D.,Anderson, K.S.,Jorgensen, W.L.
Optimization of Triarylpyridinone Inhibitors of the Main Protease of SARS-CoV-2 to Low-Nanomolar Antiviral Potency.
Acs Med.Chem.Lett., 12:1325-1332, 2021
Cited by
PubMed Abstract: Non-covalent inhibitors of the main protease (M) of SARS-CoV-2 having a pyridinone core were previously reported with IC values as low as 0.018 μM for inhibition of enzymatic activity and EC values as low as 0.8 μM for inhibition of viral replication in Vero E6 cells. The series has now been further advanced by consideration of placement of substituted five-membered-ring heterocycles in the S4 pocket of M and N-methylation of a uracil ring. Free energy perturbation calculations provided guidance on the choice of the heterocycles, and protein crystallography confirmed the desired S4 placement. Here we report inhibitors with EC values as low as 0.080 μM, while remdesivir yields values of 0.5-2 μM in side-by-side testing with infectious SARS-CoV-2. A key factor in the improvement is enhanced cell permeability, as reflected in PAMPA measurements. Compounds and are particularly promising as potential therapies for COVID-19, featuring IC values of 0.044-0.061 μM, EC values of ca. 0.1 μM, good aqueous solubility, and no cytotoxicity.
PubMed: 34408808
DOI: 10.1021/acsmedchemlett.1c00326
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (1.94 Å)
構造検証レポート
Validation report summary of 7n44
検証レポート(詳細版)ダウンロードをダウンロード

252091

件を2026-04-15に公開中

PDB statisticsPDBj update infoContact PDBjnumon